Search research articles
Contact Us
Filters
Showing results (41-50 of 110) with videos related to
Page
of 11
Sort By:
American Journal of Obstetrics & Gynecology MFM
|
October 10, 2022
Immediate postpartum care in low- and middle-income countries: A gap in healthcare quality research and practice
Emma Clarke-Deelder, Kennedy Opondo, Monica Oguttu, et al.
Cancers
|
February 25, 2022
Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
Vamsidhar Velcheti, Xiaohan Hu, Yeran Li, et al.
World Journal of Surgery
|
June 13, 2015
A Safe-Anesthesia Innovation for Emergency and Life-Improving Surgeries When no Anesthetist is Available: A Descriptive Review of 193 Consecutive Surgeries
Thomas Burke, Yogeeta Manglani, Zaid Altawil, et al.
JCO Clinical Cancer Informatics
|
August 20, 2021
Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With Pembrolizumab
Thomas Jemielita, Xiaoyun Nicole Li, Thomas Burke, et al.
BMJ Open
|
October 5, 2022
Non-anaesthetist-administered ketamine for emergency caesarean section in Kenya: cost-effectiveness analysis
Stephen Charles Resch, Sebastian Suarez, Moshood Olanrewaju Omotayo, et al.
Journal of Medical Economics
|
August 30, 2016
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States
Min Huang, Yanyan Lou, James Pellissier, et al.
Pharmacoeconomics
|
June 17, 2017
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States
Min Huang, Yanyan Lou, James Pellissier, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
January 30, 2010
A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI)
Peter Thomas Burke, Hamid Ghanbari, Patrick B Alexander, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2007
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines
Marisa A Navo, Judith A Smith, Anjali Gaikwad, et al.
Blood Pressure. Supplement
|
January 25, 2006
Characteristics of blood-pressure control in treated hypertensive patients in Croatia
Dinko Vitezić, Thomas Burke, Jasenka Mrsić-Pelcić, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 110) with videos related to
Sort By:
Page
of 11
American Journal of Obstetrics & Gynecology MFM
|
October 10, 2022
Immediate postpartum care in low- and middle-income countries: A gap in healthcare quality research and practice
Emma Clarke-Deelder, Kennedy Opondo, Monica Oguttu, et al.
Cancers
|
February 25, 2022
Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
Vamsidhar Velcheti, Xiaohan Hu, Yeran Li, et al.
World Journal of Surgery
|
June 13, 2015
A Safe-Anesthesia Innovation for Emergency and Life-Improving Surgeries When no Anesthetist is Available: A Descriptive Review of 193 Consecutive Surgeries
Thomas Burke, Yogeeta Manglani, Zaid Altawil, et al.
JCO Clinical Cancer Informatics
|
August 20, 2021
Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With Pembrolizumab
Thomas Jemielita, Xiaoyun Nicole Li, Thomas Burke, et al.
BMJ Open
|
October 5, 2022
Non-anaesthetist-administered ketamine for emergency caesarean section in Kenya: cost-effectiveness analysis
Stephen Charles Resch, Sebastian Suarez, Moshood Olanrewaju Omotayo, et al.
Journal of Medical Economics
|
August 30, 2016
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States
Min Huang, Yanyan Lou, James Pellissier, et al.
Pharmacoeconomics
|
June 17, 2017
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States
Min Huang, Yanyan Lou, James Pellissier, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
January 30, 2010
A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI)
Peter Thomas Burke, Hamid Ghanbari, Patrick B Alexander, et al.
Cancer Chemotherapy and Pharmacology
|
November 16, 2007
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines
Marisa A Navo, Judith A Smith, Anjali Gaikwad, et al.
Blood Pressure. Supplement
|
January 25, 2006
Characteristics of blood-pressure control in treated hypertensive patients in Croatia
Dinko Vitezić, Thomas Burke, Jasenka Mrsić-Pelcić, et al.
Page
of 11